Portfolio company
Prothea
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops integrated microendoscope and laser ablation systems for the diagnosis and treatment of lung cancer in a single hospital visit.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HEPTA Medical
This company develops a microwave ablation platform with integrated temperature sensors for clinicians to treat early-stage lung cancer patients using minimally invasive procedures.
Prana Thoracic
This company develops a minimally invasive electrosurgical tool for the excision of suspicious lung nodules to support early intervention for thoracic surgeons.
Noah Medical
This company develops robotic-assisted bronchoscopy platforms to help pulmonologists and surgeons perform minimally invasive lung biopsies and diagnostic procedures.
Auris Health
This company develops robotic endoscopic platforms for diagnostic and therapeutic lung procedures, serving healthcare providers and surgical teams.
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
Lightpoint
This company develops miniaturised imaging and sensing tools for intra-operative cancer detection to assist surgeons during robot-assisted procedures.
Digma Medical
This company develops endoscopic laser ablation platforms for gastrointestinal diseases and metabolic conditions for hospitals and specialist medical providers.
Trod Medical
The company develops radio frequency ablation devices for treating prostate cancer for use by urological surgeons and healthcare providers.
